A clinical trial for patients with relapsed or refractory multiple myeloma, using an experimental drug called ISB 2001 for the first time in humans

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-507071-21-01

Acronym

ISB 2001-101

Enrollment

Registered

2025-06-16

Start date

2025-08-14

Completion date

Unknown

Last updated

2025-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Relapsed/Refractory Multiple Myeloma

None listed

Sex/Gender

All

Age

18 Years to No maximum

France, Italy, Norway, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026